It was previously shown that acute pretreatment with simvastatin (1 mg/kg) significantly protects rats from renal ischemia-reperfusion injury (I/R, 45 min + 4 h
INTRODUCTION
Statins were convincingly shown to have an intriguing therapeutic potential beyond their lipid-lowering capacity (Schulz, 2005) . So called pleiotropic (lipid lowering-independent) effects of statins are attributed to their antiinflammatory, antioxidant, and/or vascular actions. In contrast to lipid lowering effects, pleiotropic actions of statins are rapid, but may be prone to tolerance (Mensah et al., 2005; Jo et al., 2007) . Protective effects of statins in experimental models of acute renal failure (ARF) were shown by different authors (Wagner et al., 2002; Davignon, 2004; Yokota et al., 2003) . The acute protection of kidneys with pleiotropic compounds may offer significant therapeutic approach in human renal ischemic-reperfusion (I/R) injury (e.g. during renal transplantation) (Torras et al., 1999; Menger and Vollmar, 2007) . It should be pointed out that renal I/R injury with a high mortality rate and resolved pharmacotherapy questions is of the leading causes of ARF (Lameire et al., 2005) . In addition, we have recently confirmed that a single intravenous dose of simvastatin exerts such a protection in rats subjected to renal I/R injury (Ne{i} et al., 2006; Todorovi} et al., 2008) . However, the optimal dose for acute pretreatment with statins in renal I/R injury remains to be elucidated. In this study we compared the protective effects of two different doses of simvastatin (1 and 3 mg/kg, i.v. bolus), injected 30 min before ischemia, 30 min before reperfusion and 5 min before reperfusion in the experimental model of renal I/R injury were compared.
MATERIAL AND METHODS

Animals and experimental design
In vivo studies were carried out using 68 male Wistar rats weighing 200-300 g (286 ± 11.3 g) and receiving a standard diet and water ad libitum. Figure 1 . Experimental design groups: 30 min before ischemia (I/R +Sim 3 30 min before I), 30 min before reperfusion (I/R + Sim 3 30 min before R) and 5 min before reperfusion (I/R + Sim 3 5 min before R). Following adaptation, I/R injury was induced by clamping both renal vascular pedicles for 45 min, followed by 4 hours of reperfusion with saline (2 ml/kg/h). In all groups during reperfusion, urine was collected and blood samples were taken and analyzed for markers of renal impairment. Methods are described in details by Chatterjee and Thiemermann (2003) , and Ne{i} et al. (2006) . Experimental design is shown in Figure 1 .
Materials
Compounds used in this study were: simvastatin (Simvastatin ® , SigmaAldrich, Poole, Dorset, UK), dimethylsulfoxide (DMSO) (Merck, Darmstadt, Germany), sodium thiopentone (Thiopental ® , Nycomed Pharma, Unterschleibheim, Germany) and nonpyrogenic saline 0.9% w/v NaCl (Hemofarm, Belgrade, Serbia).
Surgical procedures
Surgical preparation of rats and the protocol used to produce renal I/R were identical to those described previously by Chatterjee and Thiemermann, 2003 . Briefly, anesthetized rats were placed onto a homeothermic plate to maintain a stable body temperature of 37 ± 1 o C. A tracheotomy was performed to maintain airway potency and to facilitate spontaneous respiration. The right carotid artery was cannulated (PP50, internal diameter 0.58 mm, Portex, Kent, UK) and connected to a pressure transducer (Expert Haedyn 1.0 -Sistem for hemodynamic analysis, Belgrade, Serbia) for the measurement of mean arterial blood pressure and heart rate, which were displayed on a data acquisition system installed on an IBM Personal computer (IBM Computers, Belgrade, Serbia). The jugular vein was cannulated (PP25, internal diameter 0.40 mm, Portex, Kent, UK) for the administration of anesthesia, saline, vehicle (10% DMSO) or simvastatin as required. A midline laparotomy was performed, and the bladder was cannulated (PP90, internal diameter 0.76 mm, Portex, Kent, UK). Both kidneys were located, and the renal pedicles containing the artery, vein, and nerve supplying each kidney were carefully isolated. For rats subjected to I/R, bilateral renal occlusion for 45 min was performed using 3.5 cm Dieffenbach bulldog arterial clips (Holborn Surgical and Medical Instruments, Margate, Kent, UK), which were used to clamp the renal pedicles. Reperfusion commenced once the artery clips were removed. Occlusion was verified visually by change in the color of the kidneys to a paler shade and reperfusion by subsequent blushing. Sham-operated rats were subjected to sham operation, which underwent identical surgical procedures to the rats subjected to renal I/R injury, but did not undergo bilateral renal clamping and were maintained under anesthesia for the duration of the experiment (45 min + 4 h). Throughout the experimental period, body temperature was maintained at 37 ± 1 o C by a homoeothermic plate and measured by a rectal probe (Almemo 2290-1 ® , Electrical Thermometer, Hugo Sachs Electronic, Germany). At the end of all experiments, rats were euthanized using an overdose of sodium thiopentone.
Measurements of biochemical parameters
At the end of the experimental period, blood samples were collected via the carotid artery into tubes containing serum gel (Venosafe, gel-lithium heparin, Terumo, Europe). The samples were centrifuged (6000 rpm for 3 min) to separate the serum from which biochemical parameters were measured (Institute of Psychiatry, Laboratory of Biochemistry, Belgrade, Serbia). Serum creatinine levels were used as an indicator of renal (glomerular) function .
Aspartate aminotransferase (AST) and g-glutamyltransferase (g-GT), enzymes both located in the proximal tubules, were used as indicators of reperfusion injury. Urine samples were collected throughout the reperfusion period and the volume of urine produced was recorded. Urine concentrations of Na + were measured and used in conjunction with serum Na + levels to estimate fractional excretion of Na + (as an indicator of tubular dysfunction), using standard formulae.
Histological evaluation
Both kidneys of each animal were taken for histological evaluation. In all groups, post mortem samples of kidney were placed in formalin and processed through to wax. They were subsequently sectioned at 5 mm and stained with PAS (Periodic acid-Schiff). Original magnification x 20 was used. Each figure shown was randomly chosen from the series of at least 6 experiments (electronic light microscope Leica DM LS 2, type 11020518016, Microsystems, Wetzlar, Germany). The kidney samples were then graded histologically according to the severity of injury by using a predetermined scoring system (Solez et al., 1979; Doi et al., 2004) . The histological parameters evaluated were tubular necrosis, interstitial edema, loss of brush border and casts formation. A minimum of 10 fields for each kidney slide were examined and assigned for severity of changes. The scoring system used was 0, absent; 1, present; and 2, marked. Total score per kidney was calculated by addition of all scores. Blind analysis of the histological samples was performed by two independent experts (Department of Pathology, School of Medicine, Belgrade).
Statistical analysis
All values described in the text and figures are expressed as mean ± standard error of the mean (S.E.M.) of N observations. Each data point represents biochemical measurements or histological scores obtained from 6-12 separate animals. Statistical analysis was carried out using GraphPad Prism/Instat 1.1 (GraphPad Software, California, USA) using one-way analysis of variance (ANOVA) followed by Dunnett's post-hoc test. A P value of less than 0.05 was considered significant.
RESULTS
In comparison with Sham-operated animals, renal I/R injury produced significant increase in serum, urinary, and histological markers of renal dysfunction and injury, as described in details below. Also, urine volumes of I/R injured rats were increased in comparison with Sham-operated animals (not shown).
Cardiovascular responses
The mean arterial pressure (MAP) and heart rate (HR) of anesthetized rats were statistically similar under basal conditions (i.e. before I/R injury and injection of 10% DMSO or any other treatment). In rats subjected to I/R injury, renal artery occlusion caused a transient fall in MAP and HR in comparison with Shamoperated animals. I.v. bolus injection of the solution used (10% DMSO, simvastatin) did not significantly change MAP and HR (data not shown). I/R injury produced a significant increase in serum levels of both nonspecific parameters of tubular injury AST and g-GT (I/R + DMSO vs. Sham +DMSO, P<0.05). Both doses of simvastatin (1 mg/kg and 3 mg/kg) significantly decreased g-GT and AST levels in comparison with I/R + DMSO (P<0.05, in all mentioned groups, Figure 2 , panels D and E).
Effects of simvastatin (1 mg/kg or 3 mg/kg) on renal dysfunction caused by renal I/R
Time-related differences between pretreatments were not observed in these two parameters. I/R injury caused a marked increase in total histological score in comparison with sham-operated animals (I/R + DMSO vs. Sham + DMSO; P<0.01; Figure 3 , panel E). Both doses of simvastatin significantly reduced the histological scores when compared to I/R + DMSO group (P<0.01, in all mentioned groups, shown in Figure 3 , panel E). However, it should be noted that I/R-caused renal injury was not completely abolished with simvastatin (Sim 1 -, Sim 3 -groups vs. Sham + DMSO; P<0.01; shown in Figure 3 , panel E). Regarding total histological score, dose-related differences between different groups were not observed ( Figure 3 , panel E). Time-related differences between pretreatments were not observed between treated groups.
Histological analysis of simvastatin effects (1 mg/kg or 3 mg/kg) on injury caused by renal I/R
Representative light photomicrographs of a kidney section taken from rats subjected to renal I/R colored with PAS are shown in Figure 4 , panels A-H. Rouschop and Leemans, 2008) . In this paper, we have shown that pretreatment of rats with simvastatin (1 and 3 mg/kg, i.v. bolus) causes a substantial reduction in biochemical and histological parameters of renal I/R injury, but these effects do not seem to be dose-related.
Recently, we have shown that acute pretreatment with a single intravenous dose of simvastatin offered a significant protection of rat kidneys from I/R injury regardless of time of injection (30 min before ischemia or 30 min before reperfusion or 5 min before reperfusion) (Ne{i} et al., 2006; Todorovi} et al., 2008) . (Joyce et al., 2001b; Yao et al., 2006) , and gut (Naito et al., 2006) .
In the present experiments, biochemical and histological parameters of I/R injury were influenced by different doses of simvastatin in three ways: a) Sim 3 was more protective than Sim 1 (e.g. sUr, tubular necrosis score, loss of brush border score); b) Sim 1 was more protective than Sim 3 (e.g. FENa + , g-GT, interstitial edema score, cast formation score); c) Sim 1 was similar with Sim 3 (sCre, AST, total histological score). There are several possible explanations of our findings, and both pharmacodynamic and pharmacokinetic factors should be considered. However, higher doses of simvastatin do not seem to be necessary for a significant protection of injured kidneys regarding parameters of glomerular and tubular function (sCre and FENa + , respectively). The explanation of simvastatin pharmacodynamics in the present model of I/R injury should take into consideration its effect on endothelial NO production. Enhancements of the NO level by statins potentiates vasodilatation of resistant vessels, leading to preservation of tissue perfusion after I/R. Acute (3 h), transient effect of a single dose of cerivastatin on endothelial responsiveness in humans has already been reported (Omori et al., 2002) . Effects of simvastatin could be explained, at least in part, by the regulation of NO production and activity (stabilization of eNOS mRNA, stabilization of eNOS protein, or a direct influence on eNOS activity) ( The bolus administration of simvastatin in our present study might be sufficient for the maintainenance of eNOS activation via the PI3-kinase/Akt pathway during reperfusion. The rapid effects of simvastatin on PI3k/Akt/eNOS chain should also be considered, as well as the modulation of Ras-ERK signaling cascade in inflammatory cells (Zipp et al., 2007) . Besides inhibition of small GTPbinding proteins (Rho, Ras and Rac), which are regulated by isoprenoids, statins were shown to reduce oxidative stress in several ways: they suppress activation of NFkappaB (via either IkappaB-alpha or PI3k/Akt pathways), decrease parameters of in vivo LDL oxidation, and may protect paraoxonase and superoxide dismutase. Also, simvastatin decreased the production of 8-epi-PGF 2a and malondialdehyde (indicator of lipid peroxydation) in an in vivo model of myocardial I/R injury (Fassett et al., 2008) . In the most recent investigation, 0.5 mg/kg cerivastatin was administered by gavage to rats for 3 days before renal I/R. Pretreatment with cerivastatin offerd a significant protection against subsequent renal dysfunction and I/R injury that was completely abolished by tin protoporphyrin, a competitive inhibitor heme oxygenase-1 (HO-1) , suggesting the involvement of this protective enzyme. Further investigations revealed that infiltrating macrophages were the major source of this upregulated HO-1 (Gueler et al., 2007) .
Another important factor to be considered is pharmacokinetics of simvastatin. Late injection of simvastatin 5 min before reperfusion could expose the kidneys to the maximal concentration of its active form immediately at the beginning of reperfusion. The direct protection of injured kidneys by simvastatin was also possible when the drug was injected 30 min before ischemia because the uptake (passive diffusion) of simvastatin in the rat kidney tissues is rapid and high (Cl uptake of 0.911 ml/min/g tissue) (Nezasa et al., 2002) . In other words, this highly lipophylic statin could easily reach the target kidney tissue. Furthermore, sufficiently high active simvastatin levels were possibly present in the kidneys during ischemia and at the beginning of reperfusion, thus protecting tubular cells from oxidative damage.
CONCLUSION
Acute pretreatment with a single intravenous dose of simvastatin seems to give a significant protection to rat kidneys from I/R injury regardless of the time or dose of the injected drug. In other words, the effect of simvastatin does not seem to be dose-related. Our results may have therapeutic implications. Even a small dose of statin such as simvastatin could be beneficial in the prevention of acute renal failure in patients undergoing major vascular surgery for atherosclerotic disorders, particularly if they are at high risk for developing acute renal failure postoperatively, having namely pre-existing renal impairment, diabetes or old age. Overall, the potential for statins to provide protection against renal I/R injury and the cellular mechanisms involved remain to be clarified and warrant further investigation.
